0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop - Wikidata - wikimedia - TriplyDB

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

http://www.wikidata.org/entity/Q33861041

about

MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.Identification of H2O2 induced oxidative stress associated microRNAs in HLE-B3 cells and their clinical relevance to the progression of age-related nuclear cataract.

P2860

Q44463289-A4F1EA76-18D4-4775-BA97-7915AE5E7812 Q52589524-EF353D3B-A556-48F0-BA70-A51FFA4D4DE2

P2860

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

http://www.wikidata.org/entity/Q33861041

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

@ast

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

@en

type

label

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

@ast

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

@en

prefLabel

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

@ast

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

@en

P1433

Q33861041-A7B60874-406E-4B5D-A219-6D99EB65997E

P1476

Q33861041-6CC62D2A-C3CA-40BC-AA6C-B1CAD01B441A

P2093

Q33861041-11FAAC20-D5DB-426C-82D0-224E270A1D31

Q33861041-126F1D23-CE7E-4924-9611-405F87368847

Q33861041-4CF2BE69-1E01-4413-A57B-605F5D745EFE

Q33861041-57B8BE79-7C14-4831-8B67-F0BADD40F240

Q33861041-59ECF273-E447-4F5D-85D1-EA01FAB6EC0D

Q33861041-622BF838-66F7-4E1C-A203-C451F0584BC0

Q33861041-79C13612-FB43-46B4-B4B7-EBF05D59C247

Q33861041-7A874B72-0543-4D6A-8BA7-0437AEA0D643

Q33861041-820714A1-4585-44BF-9B59-9042D115C845

Q33861041-ACF4E7CB-891A-426C-A739-C411B4A5B94C

P2860

Q33861041-0B90ADD6-1444-4CEC-9F3B-2FE9D45987B0

Q33861041-12FD4D53-50A1-46FC-B1ED-3865FAFE57CC

Q33861041-13594184-C7CC-45E5-9B51-E37D2D4E68ED

Q33861041-16CC2334-E79B-4047-8D74-4D508C201307

Q33861041-1B0FB76F-7613-4C93-8125-CCE5AD03E750

Q33861041-226DECCE-3C22-47C6-9690-A1A3AAD61AD2

Q33861041-2474D82D-FEAE-4CD7-8A4E-288E0125D405

Q33861041-286637BC-543E-4D1E-9A8B-B9F76F526E70

Q33861041-295CF877-5E8C-46F6-AE8A-1209CC53F221

Q33861041-29B5DB73-6C32-46A2-B208-F2C07CF25D9A

P2888

Q33861041-16BA0A6E-F525-4F5B-9473-3BF113EF65EF

P304

Q33861041-B3A69F66-78EA-4FB9-95ED-135EDD3EC5A0

P31

Q33861041-C5BACD94-761C-4E36-BD41-F48C05D2583E

P356

Q33861041-94BBAB94-EADF-4923-8CFA-1838733F2C80

P407

Q33861041-36764EE6-3F7C-4588-AACD-ACE29B9F994E

P433

Q33861041-3EB02C4B-97D8-4051-9435-9B867290AA4D

P478

Q33861041-8C08DC79-82DA-4EE6-A40B-0F5166AD1A96

P577

Q33861041-C984A848-AA9F-4135-A66A-7477B796A32D

P6179

Q33861041-304E681C-E3B7-4813-954D-F98BF3275918

P698

Q33861041-0E4F1980-284D-46D1-8E6D-7195701EE8CC

P932

Q33861041-CF2FA8D8-F6FB-479A-BBC9-E8EB24DDD389

P356

S41598-017-04487-X

P1433

Scientific Reports

P1476

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop

@en

P2093

Bingjue Ye

http://www.w3.org/2001/XMLSchema#string

Caixia Xia

http://www.w3.org/2001/XMLSchema#string

Guohua Lou

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Liyan Shui

http://www.w3.org/2001/XMLSchema#string

Long Mao

http://www.w3.org/2001/XMLSchema#string

Min Zheng

http://www.w3.org/2001/XMLSchema#string

Shanshan Wu

http://www.w3.org/2001/XMLSchema#string

Wanhong Xu

http://www.w3.org/2001/XMLSchema#string

Wei Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

The DNA-damage response in human biology and disease

DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer

Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Loss of Nek11 Prevents G2/M Arrest and Promotes Cell Death in HCT116 Colorectal Cancer Cells Exposed to Therapeutic DNA Damaging Agents

Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.

Involvement of DNA damage response pathways in hepatocellular carcinoma.

Screening and identification of small molecule compounds perturbing mitosis using time-dependent cellular response profiles.

P2888

s41598-017-04487-x

P304

4396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-04487-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1087305653

http://www.w3.org/2001/XMLSchema#string

P698

28667294

http://www.w3.org/2001/XMLSchema#string

P932

5493669

http://www.w3.org/2001/XMLSchema#string